An observational study in Trigger Point Pain, Myofascial, sponsored by Ankara University. Recruiting at 1 site in Turkey. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2024-10-29.
Sponsored by Ankara University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 81 studies in Myofascial Pain Syndromes with a site in Turkey — 12 open to participants now, 12 under way, none of them phase 3. Myofascial Pain Syndromes · Turkey.
Among the 81 studies in Myofascial Pain Syndromes with a site in Turkey, this one has the largest planned enrollment of the 14 observational ones that give a count, is one of 9 that started in 2024, is one of 14 observational ones, reaches primary completion later than 1 of the 11 other live ones, and was the 56th registered.
340 studies on the registry are indexed under Myofascial Pain Syndromes; 67 are open to participants now.
Browse Myofascial Pain Syndromes studies →12 of the 81 studies in Myofascial Pain Syndromes with a site in Turkey are open now. Recruiting first, the newest first:
ALİEMAN · Sites in Turkey
Ages 18–65
Istanbul University · Sites in Turkey
Ages 18–55
Ankara Etlik City Hospital · Sites in Turkey
Ages 18–65
Gazi University · Sites in Turkey
Ages 18–35 · Women only
Firat University · Sites in Turkey
Ages 18–65
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 35 Myofascial Pain Syndromes studies recruiting now, 6 (17%) set no upper age limit and 26 (74%) stop at 75 or younger; 2 take children under 18; 4 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
81 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 9 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 211 is above the median of 90 across 28 observational studies indexed under Myofascial Pain Syndromes.
Median enrollment 60 across the 67 interventional studies, 110 across the 14 observational. Of the 64 that completed or were terminated, 1 (2%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 81 have an industry lead sponsor. The 10 most frequent:
Ankara University is the lead sponsor of 323 studies on the registry; 65 are open to participants now.
Ankara University has 5 studies filed under Myofascial Pain Syndromes — fewer than ten, so there is no comparison to draw.
3 of the studies in Myofascial Pain Syndromes with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07926113Medipol UniversityComparison of 26G and 30G Needles for Masseter Trigger Point Injections in Patients With Myofascial Pain Syndrome | 2027-01 |
| NCT07511751ALİEMANCOMPARISON OF THREE TREATMENT MODALITIES IN MYOFASCIAL PAIN SYNDROME | 2027-03-10 |
| NCT07904364Mardin Artuklu UniversityAgreement Between CSI and IASP Pain Classification in Chronic Cervical Myofascial Pain | 2027-06-15 |
Add all 3 to your calendar (.ics) → With an account.
Among the 81 studies in Myofascial Pain Syndromes with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this observational study is to define the safe distance that will reduce the risk of pneumothorax through ultrasonographic imaging measurements in both sitting and prone positions to ensure patient safety during these procedures. The main question[s] it aims to answer [is/are]:
The mean distance between the skin and pleura in sitting position during the inhalation and exhalation The mean distance between the skin and pleura in prone position during the inhalation and exhalation
Myofascial pain syndrome is characterized by pain and tenderness at specific points known as trigger points. Tension and spasm occur in the muscles, making it one of the most common causes of musculoskeletal pain. Various treatment options, such as TENS, dry needling, and trigger point injections, are available for the management of myofascial pain syndrome. Trigger point injection is one of the evidence based treatment methods that can provide both temporary and long-term relief.
Trigger point injections can be performed under ultrasound guidance or by blind technique. Although trigger point injection is generally be considered a safe procedure when performed by a skilled practitioner, complications may occur. These complications include pain during and after the procedure, nerve injury, bleeding, infection, and serious complications such as pneumothorax. Pneumothorax may occur when trigger point injections are administered into the chest wall muscles, particularly the trapezius, rhomboid major, or rhomboid minor muscles. Among these muscles, the rhomboid major is very thin, and the thickness of the skin, subcutaneous fat layer, and other soft tissues surrounding it varies between individuals. Since nerves, vascular structures, and the pleura are present in the deeper parts of these muscles, determining the appropriate injection depth is crucial.
In clinical practice, trigger point injections are administered by clinicians in both prone and sitting positions. To the best of our knowledge there is no studies thatinvestigates the determination of a safe distance through measurements in both the sitting and prone positions. In this study we aim to calculate the safe distance using ultrasound that will reduce the risk of pneumothorax through ultrasonographic imaging measurements in both sitting and prone positions during inhalation and exhalation to ensure patient safety during these procedures.
Patients scheduled to undergo trigger point injections due to myofascial pain
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
myofascial pain syndrome
Other: Ultrasound guided injection with local anaestethic
Volunteers will first be asked to sit on a chair with their back facing the examiner, placing their arms in a relaxed position with their head supported on a surface in front of them. The ultrasound operator will be positioned behind the volunteer. Initially, in the sitting position, volunteers will be asked to maintain normal breathing. Once an optimal ultrasound image is obtained, the image will be frozen, and measurements will be taken from the same image in sequence. The measurements to be performed are as follows: skin-fat tissue distance, skin-trapezius muscle distance, skin-rhomboid muscle distance, skin-rib distance, skin-pleura distance, and rhomboid muscle-pleura distance. These measurements, in millimeters, will be recorded in the data collection form. The same measurements will also be taken during deep inhalation and deep exhalation in the sitting position."
Volunteers will first be asked to lay prone position.The ultrasound operator will be positioned behind the volunteer. Initially, in the sitting position, volunteers will be asked to maintain normal breathing. Once an optimal ultrasound image is obtained, the image will be frozen, and measurements will be taken from the same image in sequence. The measurements to be performed are as follows: skin-fat tissue distance, skin-trapezius muscle distance, skin-rhomboid muscle distance, skin-rib distance, skin-pleura distance, and rhomboid muscle-pleura distance. These measurements, in millimeters, will be recorded in the data collection form. The same measurements will also be taken during deep inhalation and deep exhalation in the sitting position."
skin-pleura distance in sitting position
Evaluate the skin-pleura distance in sitting position during inhalation and exhalation
Time frame: 1 day
skin-pleura distance in prone position
skin-pleura distance in prone position during inhalation and exhalation
Time frame: 1 day
the correlation of skin-pleura distance and body mass index
the correlation of skin-pleura distance in sitting and prone position and body mass index
Time frame: 1 day
the correlation of skin-pleura distance and dominant hand
the correlation of skin-pleura distance in sitting and prone position and dominant hand
Time frame: 1 day
the correlation of skin-pleura distance and the chest wall diameter
the correlation of skin-pleura distance in sitting and prone position and the chest wall diameter
Time frame: 1 day
Plan to share: No
Started Oct 2024 (actual). Primary completion is estimated for Dec 2024, 2 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.